Herbert Medina

Herbert Medina is an experienced professional in the pharmaceutical and biotech industries, currently serving as the Director of Strategic Sourcing at Alexion Pharmaceuticals, Inc., focusing on AstraZeneca Rare Disease since June 2023. Prior roles include Director of Lab Operations at Immunai from March 2022 to June 2023, Head of Clinical Immune Assay at Aurobindo Pharma USA, Inc. from March 2020 to February 2022, and Senior Scientist Manager at Pfizer from June 2006 to March 2020, where expertise in vaccine clinical high throughput assays was established. Earlier experience includes serving as a Flavor Technologist at PepsiCo, contributing to the development of new flavors and products. Herbert holds an MBA from Saint Leo University, a Bachelor's degree in Biology from Pace University, and additional certificates in Project Management, Product Development, and Business Analytics from Marist College.